Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Azilsartan medoxomil
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Azilsartan medoxomil 40mg tablets
0205052ADAAABAB
|
Azilsartan medoxomil | Azilsartan medoxomil | Cardiovascular System | 177 |
|
Azilsartan medoxomil 20mg tablets
0205052ADAAAAAA
|
Azilsartan medoxomil | Azilsartan medoxomil | Cardiovascular System | 81 |
|
Azilsartan medoxomil 80mg tablets
0205052ADAAACAC
|
Azilsartan medoxomil | Azilsartan medoxomil | Cardiovascular System | 71 |
|
Edarbi 80mg tablets
0205052ADBBACAC
|
Edarbi | Azilsartan medoxomil | Cardiovascular System | 21 |
|
Edarbi 40mg tablets
0205052ADBBABAB
|
Edarbi | Azilsartan medoxomil | Cardiovascular System | 9 |
|
Edarbi 20mg tablets
0205052ADBBAAAA
|
Edarbi | Azilsartan medoxomil | Cardiovascular System | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.